A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2006
11/29/2006	EP1117692B1 Tie2 agonist antibodies
11/29/2006	EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006	EP0699194B1 5-ht4 receptor antagonists
11/29/2006	CN1871516A Combining identifying method of labeled bridged dipiperidine
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871029A Drug containing chymase inhibitor as the active ingredient
11/29/2006	CN1871010A Prophylaxis and/or treatment of portal hypertension
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1870986A Insulin secretion potentiator
11/29/2006	CN1869683A Fingerprint atlas quality investigating method of ginkgo lactone material
11/29/2006	CN1868998A Beta-(3,4) dihydroxy phenyl-alpha hydroxy borneol propionate, its synthesis method and use
11/29/2006	CN1868544A Amino-acid modified chitin nucleophic NO donor and its synthesis method
11/29/2006	CN1868533A Traditional Chinese medicine soft capsule for eliminating thrombus and removing obstruction in channels, its prepn. method
11/29/2006	CN1868532A Medicine for treating hypertension
11/29/2006	CN1868528A Traditional Chinese medicine prepns. for treating cardiovascular and cerebrovascular diseases
11/29/2006	CN1868527A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
11/29/2006	CN1868524A Shengmai dripping pills and its preparing method
11/29/2006	CN1868516A Medicine for treating fracture and injury
11/29/2006	CN1868511A Compound prepn. contg. extractive of almond and extractive of ginkgo leaf
11/29/2006	CN1868508A Medicine composition, application of the same for preparing medicine to treat and prevent cardiovascular and cerebrovascular disease
11/29/2006	CN1868507A Medicine composition, prepn. method and application thereof
11/29/2006	CN1868506A Medicine prepns. used for treating cardiovascular disease, and its prepn. method
11/29/2006	CN1868500A Medicine composition contg. tetramethylpyrazine, prepn. method and use thereof
11/29/2006	CN1868499A Method for preparing enteric capsule for treating cerebrosis
11/29/2006	CN1868498A Gutweed total flavone, its prepn. method, freeze-drying powder injection containing it and quality control method therefor
11/29/2006	CN1868496A Medicine composition, prepn. method, and quality-control method therefor
11/29/2006	CN1868493A Traditional Chinese medicine for treating haemorrhoids
11/29/2006	CN1868492A Method for preparing capsule for preventing and treating cardiovascular and cerebrovascular diseases
11/29/2006	CN1868490A Vinegar with function of preventing and treating hypertension
11/29/2006	CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn.
11/29/2006	CN1868479A Hypotensor dripping pills contg. component of reserprine, and its prepn. method
11/29/2006	CN1868477A Formula of Reynoldazine hydrochloride prepn.
11/29/2006	CN1868469A Medicine compound contg. aceglutamine
11/29/2006	CN1286980C Recombination adeno-associated virus of expression human antisense phospho lamban gene and its preparation method
11/29/2006	CN1286853C Figwort polysaccharide and its production process and use
11/29/2006	CN1286844C Medicinal composition containing angiotensin II receptor antagonist and vitamin B
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286834C Benzothiazoles compound
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286817C Process for the preparation of benazepril hydrochloride
11/29/2006	CN1286524C Use of OPN for treatment and/or prevention of neurological diseases
11/29/2006	CN1286511C Preparing method of freeze-dried powder injection for treatment of cardiovascular disease
11/29/2006	CN1286496C Angitis treating capsule
11/29/2006	CN1286480C Oral disintegrants of composite Danshen and their preparation
11/29/2006	CN1286478C Aqueous extract of leonurus heterophyllus and its application in preparing pharmaceutical composition
11/29/2006	CN1286476C Medicine for treating chronic and acute cardiomyopathy
11/29/2006	CN1286462C Medical preparation for injection
11/29/2006	CN1286461C Spray containing molsidomine
11/28/2006	US7141604 Administering to a patient citalopram or salts to treat hypertension and hypotension
11/28/2006	US7141597 1 ((+)-(S)-4-[1-(2,3-dimethyl-phenyl)-ethyl]-1-1,3-dihydro-imidazole-2-thione) for treatment of chronical pain, diabetes, hyperglycemia, hypertriglyeridemia, decreased levels of blood insulin and hyperlipidemia
11/28/2006	US7141591 e.g., 2-methyl-2-{4-[3-(4-tert-Butyl-phenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-2-methyl-phenoxy}propionic acid or its ethyl ester; dyslipidemia, syndrome X, heart failure, hypercholesteremia, cardiovascular disease, diabetes, anorexia, etc.
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141569 Antiviral pyrazolopyridine compounds
11/28/2006	US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141555 Water solubility, bioavailability, oral administration; unit dosage
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2239853C Indane dimer compounds and their pharmaceutical use
11/28/2006	CA2173582C Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
11/28/2006	CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2137203C Protein kinase c inhibitors
11/23/2006	WO2006125211A1 A1 adenosine receptor agonists
11/23/2006	WO2006125180A1 Piperazine derivatives and their uses as therapeutic agents
11/23/2006	WO2006125179A1 Tricyclic compounds and their uses as therapeutic agents
11/23/2006	WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	WO2006124739A1 The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders
11/23/2006	WO2006123678A1 Stable tablet containing droxidopa
11/23/2006	WO2006123674A1 Angiogenesis inhibitor containing amine derivative as active ingredient
11/23/2006	WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006	WO2006123618A1 Oxidative stress inhibitor
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006	WO2006122977A2 PROCESS FOR PREPARING 3α(β)-7α(β)-DIHYDROXY-6α(β)-ALKYL-5β-CHOLANIC ACID
11/23/2006	WO2006122854A1 Therapeutic compositions comprising embryonic stem cells of mice
11/23/2006	WO2006105217A3 Spirocyclic thrombin receptor antagonists
11/23/2006	WO2006102072A3 Use of a pa131 polypeptide in treatment of atherosclerosis
11/23/2006	WO2006089120A3 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
11/23/2006	WO2006084757A3 Combination of ca/mg salt of valsartan with an antidiabetic agent
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	WO2006083780A3 Glucuronidated nebivolol
11/23/2006	WO2006083779A3 Pharmaceutical composition comprising hydroxylated nebivolol
11/23/2006	US20060264639 crystalline rosiglitazone maleate filtration
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264507 Formoterol tartrate process and polymorph
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders

1 ... 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 ... 1595